Cue Biopharma, Inc. (CUE) Tops Q1 EPS by 4c

Cue Biopharma, Inc. (NASDAQ: CUE) reported Q1 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $733.33 thousand.

For earnings history and earnings-related data on Cue Biopharma, Inc. (CUE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Cue Biopharma Inc. (CUE) files for 1.51M share offering by selling stockholders